Last $2.37 USD
Change Today +0.005 / 0.21%
Volume 24.5K
TRGT On Other Exchanges
Symbol
Exchange
NASDAQ GS
As of 8:10 PM 10/29/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Jeffrey P. Brennan

Former Chief Business Officer and Senior Vice President of Business & Commercial Development, Targacept, Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 1 different industries.

56--
As of Fiscal Year 2012

Background*

Mr. Jeffrey P. Brennan served as Chief Business Officer and Senior Vice President of Business & Commercial Development at Targacept Inc. from March 2010 to March 31, 2013. Mr. Brennan served as Vice President of Business & Commercial Development at Targacept Inc. since September 2003 until March 2010. Mr. Brennan from September 2000 to May 2003, he was vice president, commercial development at Sanofi-Synthlabo Inc., a publicly traded global pharmaceutical company based ...

Read Full Background

Corporate Headquarters*

100 North Main Street
Winston-Salem, North Carolina 27101

United States

Phone: 336-480-2100
Fax: 336-480-2107

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

BS
Central Connecticut State University

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
TRGT:US $2.37 USD +0.005

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Ian C. Read Chairman, Chief Executive Officer and Chairman of Executive Committee
Pfizer Inc.
$1.8M
John C. Lechleiter Ph.D.Chairman, Chief Executive Officer and President
Eli Lilly and Company
$1.5M
Joseph Jimenez MBAChief Executive Officer and Member of Executive Committee
Novartis AG
SFr.3.1M
Robert H. Gundel Ph.D., M.B.A.Chief Executive Officer, President, Non Independent Director and Member of Financing Committee
Amorfix Life Sciences Ltd.
C$283.3K
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact TARGACEPT INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.